Axcelis Technologies, Inc. (ACLS)
NASDAQ: ACLS · Real-Time Price · USD
90.26
-9.68 (-9.69%)
Nov 20, 2026, 4:00 PM EST - Market closed
Company Description
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and the Asia Pacific.
The company provides high energy, high current, and medium current implanters for various application requirements.
It also offers aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training.
The company sells its equipment and services to semiconductor chip manufacturers through its direct sales force.
Axcelis Technologies, Inc. was founded in 1978 and is headquartered in Beverly, Massachusetts.
Axcelis Technologies, Inc.
| Country | United States |
| Founded | 1995 |
| IPO Date | Jul 11, 2000 |
| Industry | Semiconductor Equipment & Materials |
| Sector | Technology |
| Employees | 1,465 |
| CEO | Russell Low |
Contact Details
Address: 108 Cherry Hill Drive Beverly, Massachusetts 01915-1088 United States | |
| Phone | 978 787 4000 |
| Website | axcelis.com |
Stock Details
| Ticker Symbol | ACLS |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001113232 |
| CUSIP Number | 054540208 |
| ISIN Number | US0545402085 |
| Employer ID | 34-1818596 |
| SIC Code | 3559 |
Key Executives
| Name | Position |
|---|---|
| Dr. Russell J. Low Ph.D. | Chief Executive Officer, President and Director |
| Gregory F. Redinbo Ph.D. | Chief Strategy Officer and Executive Vice President of Strategic Marketing & Technology |
| Eileen J. Evans Esq. | Executive Vice President of Human Resources and Legal, General Counsel and Secretary |
| Gerald M. Blumenstock | Executive Vice President and GM of Implant Business Unit (IBU) |
| Dr. Christopher J. Tatnall Ph.D. | Executive Vice President of Global Customer Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 5, 2026 | 10-Q | Quarterly Report |
| Nov 5, 2026 | SCHEDULE 13G/A | Filing |
| Nov 5, 2026 | 8-K | Current Report |
| Nov 2, 2026 | 425 | Filing |
| Nov 2, 2026 | 8-K | Current Report |
| Oct 27, 2026 | 8-K | Current Report |
| Aug 6, 2026 | 10-Q | Quarterly Report |
| Aug 6, 2026 | SCHEDULE 13G/A | Filing |
| Aug 6, 2026 | 8-K | Current Report |
| Jul 14, 2026 | SCHEDULE 13G/A | Filing |
Investor Relations Documents
Annual and quarterly reports, earnings releases, and presentation slides